BDX Becton Dickinson
NYSE · SEC CIK 10795 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.78M 21 sales by 5 insiders
- Filings on record
- 294 since 2021-08-04, latest 2026-09-03 19:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| SCOTT BERTRAM L | Dir | — | $212.3K |
| Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| Menziuso Peter | EVP, Pres, BDI | — | — |
| Roque Vitor | Interim CFO | — | — |
| Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| Shan David | EVP, Chief ISC Off | — | — |
| Waldstreicher Joanne | Dir | — | — |
Transactions 334
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-11 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale+OE | $277.85 | -2,974 | 4,199 | -41% | -$826.3K |
| 2023-08-09 | 2023-08-08 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $277.13 | -1,300 | 5,157 | -20% | -$360.3K | |
| 2023-07-24 | 2023-07-24 | BDX | Waldstreicher Joanne | Dir | A - Grant | $0.00 | +419 | 419 | New | $0 | |
| 2023-07-06 | 2023-07-01 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | A - Grant | $0.00 | -47 | 1,827 | -3% | $0 | |
| 2023-05-02 | 2023-05-01 | BDX | Quinn Michelle | EVP, GC | F - Tax | $0.00 | -99 | 3,280 | -3% | $0 | |
| 2023-04-06 | 2023-04-04 | BDX | Neal Shana Carol | CHRO | A - Grant | $0.00 | +8,229 | 16.9K | +95% | $0 | |
| 2023-04-06 | 2023-04-04 | BDX | Neal Shana Carol | CHRO | F - Tax | $0.00 | -731 | 8,680 | -8% | $0 | |
| 2023-03-06 | 2023-03-02 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | F - Tax | $0.00 | -650 | 7,187 | -8% | $0 | |
| 2023-03-03 | 2023-03-01 | BDX | Spoerel Thomas J | SVP, Ctrl, Chief Acct Off | F - Tax | $0.00 | -35 | 1,874 | -2% | $0 | |
| 2023-03-03 | 2023-03-01 | BDX | Garrison Michael David | EVP, Pres Medical | F - Tax | $0.00 | -193 | 6,457 | -3% | $0 | |
| 2023-03-03 | 2023-03-01 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | F - Tax | $0.00 | -418 | 7,837 | -5% | $0 | |
| 2023-02-06 | 2023-02-03 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $248.60 | -1,421 | 4,119 | -26% | -$353.3K | |
| 2023-01-26 | 2023-01-24 | BDX | ECKERT R ANDREW | Dir | A - Grant | $0.00 | +848 | 6,992 | +14% | $0 | |
| 2023-01-26 | 2023-01-26 | BDX | Fraser Claire | Dir | A - Grant | $0.00 | +848 | 22.3K | +4% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +848 | 29.2K | +3% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | RING TIMOTHY M | Dir | A - Grant | $0.00 | +848 | 78.8K | +1% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | SCOTT BERTRAM L | Dir | A - Grant | $0.00 | +848 | 33.8K | +3% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | Byington Carrie L | Dir | A - Grant | $0.00 | +848 | 1,924 | +79% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +848 | 4,653 | +22% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | BURZIK CATHERINE M | Dir | A - Grant | $0.00 | +848 | 13.4K | +7% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | Brown William M | Dir | A - Grant | $0.00 | +848 | 1,586 | +115% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | LARSEN MARSHALL O | Dir | A - Grant | $0.00 | +848 | 28.9K | +3% | $0 | |
| 2023-01-05 | 2022-12-21 | BDX | Khichi Samrat S. | EVP, GC | G - Gift | $0.00 | -19 | 9,251 | -0.2% | $0 | |
| 2022-12-14 | 2022-12-13 | BDX | Khichi Samrat S. | EVP, GC | G - Gift | $0.00 | -40 | 9,270 | -0.4% | $0 | |
| DM | 2022-11-29 | 2022-11-26 | BDX | Goette Roland | EVP, Pres EMEA | A - Grant | $0.00 | +1,819 | 12.5K | +17% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Goette Roland | EVP, Pres EMEA | F - Tax | $0.00 | -99 | 13.6K | -0.7% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | A - Grant | $0.00 | +2,501 | 6,251 | +67% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | F - Tax | $0.00 | -711 | 5,540 | -11% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Neal Shana Carol | CHRO | A - Grant | $0.00 | +1,812 | 9,411 | +24% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Garrison Michael David | EVP, Pres Medical | A - Grant | $0.00 | +2,790 | 6,044 | +86% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Garrison Michael David | EVP, Pres Medical | F - Tax | $0.00 | -617 | 6,650 | -8% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +3,087 | 12.2K | +34% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -269 | 12.0K | -2% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +1,816 | 5,147 | +55% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | F - Tax | $0.00 | -115 | 8,255 | -1% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | A - Grant | $0.00 | +1,045 | 8,370 | +14% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | A - Grant | $0.00 | +462 | 1,078 | +75% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | F - Tax | $0.00 | -46 | 1,130 | -4% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Khichi Samrat S. | EVP, GC | F - Tax | $0.00 | -1,908 | 9,310 | -17% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Khichi Samrat S. | EVP, GC | A - Grant | $0.00 | +5,290 | 11.2K | +89% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | A - Grant | $0.00 | +669 | 1,847 | +57% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | F - Tax | $0.00 | -232 | 1,909 | -11% | $0 |
| D | 2022-11-29 | 2022-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | F - Tax | $0.00 | -10.5K | 47.7K | -18% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | A - Grant | $0.00 | +29.3K | 58.1K | +101% | $0 |
| D | 2022-11-18 | 2022-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | D - Sale to Iss | $222.08 | -2,996 | 11.9K | -20% | -$665.4K |
| D | 2022-11-18 | 2022-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | M - OptEx | $74.94 | +4,617 | 14.9K | +45% | +$346.0K |
| 2022-09-29 | 2022-09-07 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -506 | 9,135 | -5% | $0 | |
| 2022-09-06 | 2022-09-01 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +2,674 | 9,641 | +38% | $0 | |
| D | 2022-08-17 | 2022-08-15 | BDX | Polen Thomas E Jr | COB, CEO, Pres, Dir | M - OptEx | $167.91 | +15.0K | 43.9K | +52% | +$2.52M |
| D | 2022-08-17 | 2022-08-15 | BDX | Polen Thomas E Jr | COB, CEO, Pres, Dir | S - Sale+OE | $265.13 | -9,500 | 28.9K | -25% | -$2.52M |
| D | 2022-08-17 | 2022-08-15 | BDX | Polen Thomas E Jr | COB, CEO, Pres, Dir | D - Sale to Iss | $265.13 | -5,500 | 38.4K | -13% | -$1.46M |
| 2022-08-17 | 2022-08-15 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale | $265.00 | -475 | 3,331 | -12% | -$125.9K | |
| D | 2022-08-11 | 2022-08-09 | BDX | Polen Thomas E Jr | EVP | M - OptEx | $147.68 | +3,825 | 32.7K | +13% | +$564.9K |
| D | 2022-08-11 | 2022-08-09 | BDX | Polen Thomas E Jr | EVP | D - Sale to Iss | $260.00 | -2,173 | 30.5K | -7% | -$565.0K |
| D | 2022-08-11 | 2022-08-09 | BDX | Polen Thomas E Jr | EVP | S - Sale+OE | $260.00 | -1,652 | 28.9K | -5% | -$429.5K |
| DM | 2022-08-11 | 2022-08-09 | BDX | Khichi Samrat S. | EVP, GC | M - OptEx | $100.36 | +26.8K | 18.4K | New | +$2.69M |
| DM | 2022-08-11 | 2022-08-09 | BDX | Khichi Samrat S. | EVP, GC | D - Sale to Iss | $260.44 | -10.3K | 13.2K | -44% | -$2.69M |
| DM | 2022-08-11 | 2022-08-08+ | BDX | Khichi Samrat S. | EVP, GC | S - Sale+OE | $260.44 | -16.5K | 5,928 | -74% | -$4.29M |
| 2022-07-12 | 2022-07-08 | BDX | Grover Rishi | EVP, Chief ISC Off | A - Grant | $0.00 | +9,340 | 9,439 | +9,434% | $0 | |
| A | 2022-07-11 | 2022-07-01 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | A - Grant | $0.00 | +414 | 1,472 | +39% | $0 |
| 2022-07-06 | 2022-07-01 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | A - Grant | $0.00 | +420 | 1,478 | +40% | $0 | |
| 2022-06-24 | 2022-06-17 | BDX | Lim James C | EVP | A - Grant | $0.00 | +3,280 | 23.9K | +16% | $0 | |
| D | 2022-06-09 | 2022-06-07 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | M - OptEx | $147.68 | +1,026 | 2,070 | +98% | +$151.5K |
| D | 2022-06-09 | 2022-06-07 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | D - Sale to Iss | $260.00 | -583 | 1,487 | -28% | -$151.6K |
| D | 2022-06-09 | 2022-06-07 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | S - Sale+OE | $260.00 | -443 | 1,058 | -30% | -$115.2K |
| 2022-05-10 | 2022-05-06 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale | $256.00 | -475 | 3,806 | -11% | -$121.6K | |
| 2022-04-06 | 2022-04-06 | BDX | Neal Shana Carol | CHRO | A - Grant | $0.00 | +7,525 | 7,599 | +10,169% | $0 | |
| 2022-03-03 | 2022-03-01 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | F - Tax | $0.00 | -35 | 1,044 | -3% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | BDX | Ezell Antoine C | EVP, Pres, CMO, NA | F - Tax | $0.00 | -886 | 7,325 | -11% | $0 |
| 2022-03-01 | 2022-02-28 | BDX | Brown William M | Dir | A - Grant | $0.00 | +714 | 714 | New | $0 | |
| DM | 2022-02-28 | 2022-02-25 | BDX | Larson Betty D | CHRO, EVP HR | M - OptEx | $188.11 | +46.7K | 9,556 | New | +$8.78M |
| DM | 2022-02-28 | 2022-02-25 | BDX | Larson Betty D | CHRO, EVP HR | D - Sale to Iss | $271.90 | -32.3K | 6,473 | -83% | -$8.78M |
| DM | 2022-02-28 | 2022-02-25 | BDX | Larson Betty D | CHRO, EVP HR | S - Sale+OE | $271.90 | -14.4K | 5,872 | -71% | -$3.91M |
| 2022-02-14 | 2022-02-11 | BDX | Campion Simon D | EVP, Segment Pres | G - Gift | $0.00 | -50 | 10.3K | -0.5% | $0 | |
| 2022-02-10 | 2022-02-08 | BDX | Khichi Samrat S. | EVP, GC | G - Gift | $0.00 | -375 | 5,928 | -6% | $0 | |
| 2022-02-10 | 2022-02-08 | BDX | Fraser Claire | Dir | S - Sale | $271.70 | -841 | 21.6K | -4% | -$228.5K | |
| D | 2022-02-07 | 2022-02-03 | BDX | Conroy Alexandre | EVP of Integrated Supply Chain | D - Sale to Iss | $270.16 | -6,377 | 27.7K | -19% | -$1.72M |
| D | 2022-02-07 | 2022-02-03 | BDX | Conroy Alexandre | EVP of Integrated Supply Chain | S - Sale+OE | $270.16 | -6,410 | 21.3K | -23% | -$1.73M |
| D | 2022-02-07 | 2022-02-03 | BDX | Conroy Alexandre | EVP of Integrated Supply Chain | M - OptEx | $134.73 | +12.8K | 34.0K | +60% | +$1.72M |
| 2022-01-31 | 2022-01-27 | BDX | Campion Simon D | EVP, Segment Pres | F - Tax | $0.00 | -190 | 10.4K | -2% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | BURZIK CATHERINE M | Dir | A - Grant | $0.00 | +820 | 12.5K | +7% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | LARSEN MARSHALL O | Dir | A - Grant | $0.00 | +820 | 23.8K | +4% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | Melcher David F | Dir | A - Grant | $0.00 | +820 | 6,180 | +15% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | Fraser Claire | Dir | A - Grant | $0.00 | +820 | 22.4K | +4% | $0 | |
| 2022-01-27 | 2022-01-25 | BDX | RING TIMOTHY M | Dir | A - Grant | $0.00 | +820 | 77.8K | +1% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Byington Carrie L | Dir | A - Grant | $0.00 | +820 | 1,042 | +369% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +820 | 3,777 | +28% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | SCOTT BERTRAM L | Dir | A - Grant | $0.00 | +820 | 31.9K | +3% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | ECKERT R ANDREW | Dir | A - Grant | $0.00 | +820 | 6,216 | +15% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +820 | 18.7K | +5% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Pomeroy Claire | Dir | A - Grant | $0.00 | +820 | 9,982 | +9% | $0 | |
| DM | 2021-12-17 | 2021-12-16 | BDX | Larson Betty D | CHRO, EVP HR | S - Sale+OE | $255.00 | -3,341 | 8,661 | -28% | -$852.0K |
| D | 2021-12-17 | 2021-12-16 | BDX | Larson Betty D | CHRO, EVP HR | D - Sale to Iss | $255.00 | -341 | 9,213 | -4% | -$87.0K |
| D | 2021-12-17 | 2021-12-16 | BDX | Larson Betty D | CHRO, EVP HR | M - OptEx | $97.14 | +893 | 9,554 | +10% | +$86.7K |
| 2021-12-09 | 2021-12-07 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | S - Sale | $250.00 | -233 | 1,079 | -18% | -$58.2K | |
| D | 2021-11-30 | 2021-11-26 | BDX | Conroy Alexandre | EVP of Integrated Supply Chain | F - Tax | $0.00 | -863 | 19.9K | -4% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Conroy Alexandre | EVP of Integrated Supply Chain | A - Grant | $0.00 | +2,535 | 21.3K | +14% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +2,608 | 6,967 | +60% | $0 |
| M | 2021-11-30 | 2021-11-26 | BDX | Reidy Christopher R | CFO, EVP of Administration | A - Grant | $0.00 | +4,998 | 29.7K | +20% | $0 |
| 2021-11-30 | 2021-11-26 | BDX | Reidy Christopher R | CFO, EVP of Administration | F - Tax | $0.00 | -1,132 | 28.6K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations